Biomedical, Clinical & Life Sciences

V Foundation Adult Translational Cancer Research Award 2025

Apply to Internal Competition // Limit: 2 (1 Translational nominee, 1 All-Star Translational nominee) // Tickets Available: 2 

The University of Arizona Cancer Center (UACC) can nominate up to two proposals: one Translational nominee and one All-Star Translational nominee (if eligible) for the V Foundation Adult Translational Cancer Research Award 2025. 

For more information please contact: UACC-PreAward.

Purpose of Award:

The UACC is seeking nominations for the Translational Adult Cancer Research Grant which advances basic laboratory discoveries towards clinical use, ultimately improving human health and is restricted to adult cancer research.

This Translational grant is restricted to adult cancer research in the preclinical or translational space with a focus on bench-to-bedside strategies. Research on ANY adult cancer type can be funded. Applicants may propose cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to test hypotheses, develop biomarkers, or mechanisms. The research must apply in a direct way to human beings within 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial or conducting an investigator-initiated trial with laboratory correlates that test hypotheses. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Funding Type
Internal Deadline
External Deadline
3/18/2025

Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Competitive Supplements (SIPS)

Limit: 1 // Tickets Available: 0 

K. Ellingson (Public Health) 

Eligibility: 
Only one application per SIP per institution is allowed (e.g., multiple applications for the same SIP (listed in Section VIII) from the same institution are NOT permitted).

Purpose:
This Notice of Funding Opportunity (NOFO) invites applications from CDC Health Promotion and Disease Prevention Research Centers (PRCs), selected for funding under RFA-DP-24-004, to apply for supplemental funding to conduct Special Interest Research Projects (SIPs) to inform public health practice. PRCs will conduct high-quality applied health promotion and disease prevention research projects in real-world settings to identify, design, test, evaluate, disseminate, and translate interventions (i.e., programs, practices, policies, or strategies) to prevent and reduce risk for the leading causes of illness, disability, and death in the United States.

Funding Type
Internal Deadline
External Deadline
February 28, 2025

NIH PAR-23-077: Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) - May 2025 Deadline

Apply to Internal Competition // Limit: 2 // Tickets Available: 2

Number of Applications
The NIH will not accept duplicate or highly overlapping applications under review at the same time, per 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Two applications per institution (with a Unique Entity Identifier ) and a unique NIH eRA Institutional Profile File (IPF) number) are allowed per review round. The same or a similar topic may be submitted for subsequent review rounds involving the same or a similar team, but must be presented as a New application, not a Resubmission.

Applications that are not considered to be within the NIGMS mission will not be reviewed. Eligibility and appropriateness to the NIGMS mission will be evaluated again after review and prior to funding. Applications outside the NIGMS mission will not be funded. Given that only two applications are permitted per institution per review round, it is important to contact NIGMS staff before committing to any particular team and its topic area.

Purpose: 
This Funding Opportunity Announcement (FOA) is designed to support highly integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to address ambitious and challenging research questions that are within the mission of NIGMS. Project goals should not be achievable with a collection of individual efforts or projects. Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Teams are encouraged to consider far-reaching objectives that will produce major advances in their fields.

This FOA is not intended for applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies, or infrastructure development.

Funding Type
Internal Deadline
External Deadline
5/28/2025
Solicitation Type

2025 Pediatric Cancer Research Foundation Grants

Request Ticket // Limit: 4* (1 per grant type) // Tickets Available: 4

Legacy Researcher Grant // Limit 1 // Tickets Available: 1

Translational Research Grant // Limit: 1 // Tickets Available: 1

Emerging Investigator Fellowship Grant // Limit: 1 // Tickets Available: 1

Donor Designated Grant Program // Limit: 1 // Tickets Available: 1

Eligibility
Provide the name of the Institution, Principal Investigator and their title. An institution may only submit one LOI per award type. Multiple LOIs should not be submitted by the same researcher. 

Grant Categories 
The Pediatric Cancer Research Foundation awards four types of research grants: 

  1. Legacy Researcher Grant (up to $100,000 per year, up to 2 years for translational research and up to $150,000 per year, for three years, for basic science research) 
    This grant is given to a long-standing PCRF-funded researcher for at least five years, who has demonstrated consistent progress and outcomes in pediatric cancer research. This funding category aims to support and sustain ongoing initiatives, ensuring that momentum is maintained on critical projects with potential for cures.  
  2. Translational Research Grants (up to $100,000 per year, up to 2 years)  
    This grant is given to single or multi-institutional programs that involve open, cancer clinical trials or consortia, and implement new approaches to therapy. These grants support “bench to bedside” research, whose endpoint is often the planning or initiation of a clinical trial. 
  3. Emerging Investigator Fellowship Grants (up to $75,000 for one year) 
    These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. Applicants must have completed two years of their fellowship or not more than two years as a junior faculty instructor or assistant professor at the start of the award period. These grants encourage and cultivate the best and brightest researchers of the future. 
  4. Donor Designated Grant Programs 
    These grants fund projects in communities or regions local to the specific donor or fundraising activity. Outside contributing organizations, fundraisers and donors work with the Foundation to identify a specific project and/or specific doctor, focus on a specific disease type, facility or awareness program. Grants can be for any specific amount as designated by the donor or contributing organization. PCRF will not accept grant application without an approved Letter of Intent (LOI). Please refer to the guidelines contained in this document for the specific guidelines. 
     
Funding Type
External Deadline
April 1, 2025 at 5pm PST (LOI)

HRSA-25-069 - Addiction Medicine Fellowship Program

Limit: 1 // Tickets Available: 0 

E. Gumm (Psychiatry - COM-T)

Application Limits
You may not submit more than one application. If you submit more than one
application, we will only accept the last on-time submission.|

If an entity applies as part of a consortium, the entity is not eligible to submit a
separate, stand-alone application.


Purpose
The purpose of the Addiction Medicine Fellowship (AMF) program is to expand the
number of fellows at accredited AMF and Addiction Psychiatry Fellowship (APF)
programs trained as addiction medicine specialists who practice in medically
underserved, community-based settings that integrate primary care with mental health
disorder and substance use disorder (SUD) prevention and treatment services. The
fellowship must include training in prevention and treatment services in medically
underserved, community-based settings, including in rural areas, that do not have
access or have limited access to SUD treatment. The program includes training for both
addiction medicine and/or addiction psychiatry fellows. Its goal is to increase the
number of physicians who are board-certified specialists in addiction medicine or
addiction psychiatry who will serve in medically underserved community-based
settings, including in rural areas, once trained. The program supports training to:
 

  • Increase the number of fellows trained to practice addiction medicine and
    addiction psychiatry in rural and other medically underserved community-based
    settings.
  • Establish partnerships with clinical rotation sites in rural or other underserved
    areas, that focus on the integration of primary care with mental health and SUD
    prevention and treatment services.
  • Increase fellows’ knowledge and ability to assist their patients with referrals to
    navigate the legal and social systems related to patients’ clinical or care needs.
  • Increase awareness of the specialty and reduce provider stigma to increase the
    number of physicians interested in pursuing careers in addiction medicine and
    addiction psychiatry through the provision of clinical rotations that expose
    medical residents to practice in these specialties and through education and
    consultation.
Funding Type
Internal Deadline
External Deadline
2/28/2025

Pew Charitable Trusts: 2026 Pew Biomedical Scholars

Apply to Internal Competition // Limit: 1 // Tickets Available: 1 

The current grant level is $300,000; $75,000 per year for a four-year period. For the 2026 award, one nomination will be invited from each of the participating institutions listed at the bottom of this page.

Eligibility

  • Candidates must meet all of the following eligibility requirements:
  • Hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
  • As of Sept. 3, 2025, run an independent lab and hold a full-time appointment at the rank of assistant professor. (Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible).
    • Current appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible to apply.
  • Must not have been appointed as an assistant professor and run an independent lab at any institution prior to June 11, 2021, whether or not such an appointment was on a tenure track. Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this four-year limit. Candidates who need an exception on the four-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
    • Please note that the eligibility criteria above have been temporarily expanded to account for COVID-related lab shutdowns. This extension will end after this upcoming application cycle. Beginning next year, the eligibility window for the 2027 grant will revert to the three-year period. Please direct any questions to the program office at scholarsapp@pewtrusts.org.
  • May apply to the program a maximum of two times. All applicants must be nominated by their institution and must complete the 2026 online application.
  • If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
  • May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.

Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Ideas with the potential to produce an unusually high impact are encouraged. Selection of the successful candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards, and publications. In evaluating the candidates, the National Advisory Committee gives considerable weight to both the project proposal and the researcher, including evidence that the candidate is a successful independent investigator and has the skill set needed to carry out their high-impact proposal.

Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew scholars program. If you have questions concerning eligibility, please contact Pew Biomedical Programs (scholarsapp@pewtrusts.org) in advance of applying.

Funding Terms

An award of $75,000 per year for four years will be provided to the sponsoring institution for use by the scholar, subject to annual review of the scholar’s progress. Grant agreements will be issued in August of the award year. The awarded funds may be used at the discretion of the Pew scholar, for personnel, equipment, supplies, or travel directly related to the scholar's research and as to best advance his or her research and career.

  • The amount of the award that may be used for the principal investigator’s salary is limited to $12,500 per year (including benefits) or $50,000 over the duration of the grant. There are no limits on student or postdoctoral salaries.
  • Not more than 8 percent ($24,000) of the total award value may be allocated for facilities and administration (F&A) charges or indirect costs (IDCs).
  • Should the funds not be immediately required, they may be accumulated and carried over through the grant period and, with written approval of the program office, the grant may receive a no-cost extension for one additional year (without additional funds).
  • Subawards are allowed.


 

Funding Type
Internal Deadline
External Deadline
May 14, 2025 (Nomination)
Solicitation Type

W.M. Keck Foundation: Science & Engineering AND Medical Research Programs - Fall 2025

U of A may submit eight (8) concept papers: four (4) in medical sciences and four (4) in science & engineering.

Medical Research: Apply to Internal Competition // Limit: 4 // Available: 4 

Science and Engineering - Apply to Internal Competition // Limit: 4 // Available: 4

Required U or A pre-proposal elements

The U of A pre-proposal contains the following required sections:

  1. Overview
  2. Methodology
  3. Justification for Keck Funding
  4. Key Personnel
  5. Estimated Budget

A template is provided in the documents section of this limited submission. Use this template, complete it, and upload it as a PDF as part of this limited submission opportunity.

Uploaded as a PDF:

  1. One-page Concept Paper based on attached template.
  2. PI BioSketch or CV
    Agency-specific BioSketch preferred. There is a 5-page limit on CVs

Program Description

Full sponsor guidelines https://www.wmkeck.org/research-overview/

Post selection as one of the pre-proposals, a concept review Zoom will be held with the W.M. Keck Foundation, RDS, and the UA Foundation in January will determine which one medical research and one science and engineering concept paper will be moved to a Phase 1 Submission.

The W.M. Keck Foundation Research Program uses a three-step process for this opportunity. The first step is a Concept paper. The next steps are by the foundation’s invitation. U of A review criteria reflect previous interactions with the W.M. Keck Foundation. Proposals should focus on basic, fundamental science with broad applications. Grants range from $1 million to $5 million and are typically $2 million or less, and more specifically in the $1.2 to $1.3 million range.

The proposed work should show a significant leap forward rather than an extension of existing work.

To be considered by Keck, applicants must have a statement expressing that the project is not a good fit due to risk (rather than technical or theoretical fit) or a decline from a federal program where the summary statement or individual reviews highlight the incredible novelty, but the high-risk nature that makes it difficult to fund at the federal level.

The Science and Engineering Research Program seeks to benefit humanity by supporting high-risk/high-impact projects that are distinctive and novel in their approach to intractable problems, push the edge of their field, or question the prevailing paradigm. Past grants have been awarded to support pioneering science and engineering research and the development of promising new technologies, instrumentation, or methodologies.

The Medical Research Program seeks to advance the frontiers of medicine to benefit humanity by supporting high-risk/high-impact projects that are distinctive and novel in their approach to intractable problems, push the edge of their field, or question the prevailing paradigm. Past grants have supported pioneering biological research, basic research, and the development of promising new technologies. The Keck Foundation does NOT fund work that is clinical, applied, or translational; treatment trials; or research for the sole purpose of drug development.

Both senior and early career investigators are encouraged to apply. Team approaches, including interdisciplinary teams, are encouraged.

Internal Deadline
External Deadline
May 1, 2025
Solicitation Type

NIH RFA-AG-24-001: 2025 Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)

Apply to Internal Competition  // Limit: 1 // Tickets Available: 1

 

This Funding Opportunity Announcement (FOA) invites applications from institutions proposing to establish, or renew, an Alzheimer's Disease Research Center (ADRC).

NIA-designated ADRCs serve as a national resource for research on the nature of Alzheimer’s disease (AD) and AD-related dementias (ADRD) and the development of more effective approaches to prevention, diagnosis, care, and therapy. They create shared resources that support dementia-relevant research, and they collaborate and coordinate their research efforts with other NIH-funded programs and investigators.

Funding Type
Internal Deadline
External Deadline
September 7, 2025
Solicitation Type

Breast Cancer Alliance - Young Investigators and Exceptional Project Grants

Limit: 2 // Available: 0

The Breast Cancer Alliance will accept a maximum of two LOIs per institution (Exceptional Projects Grant OR Young Investigators Grant)

Exceptional Projects Grant 
K. Fischer (Gurtner Laboratory - COM-T)
C. Lim (Public Health) 

Young Investigators Grant

YOUNG INVESTIGATORS GRANT
To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant.  

This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support, but who design and conduct their own independent research projects. 

The term of the Young Investigator Grant is two years, beginning on March 1, 2026. The grant provides salary support and project costs for a total of a $125,000, distributed over a two-year period. 

Indirect costs, which are included in the $125,000 award, must be limited to 8% of total direct costs. 

Researchers should coordinate with their institutions, as BCA will accept a maximum of ONLY TWO LOIs PER INSTITUTION (YIG or XP.)

Qualifications 

Applicants for the 2026 award:

  • Must not have held a tenure track faculty or tenure track research position for more than four years following completion of their training, as of March 1, 2026
  • Must not have been or are not a principal investigator on an NIH R01 or equivalent national/international non-mentored award as of March 1, 2026
  • Must dedicate at least 50% of their work effort to research
  • Must be at an institution located in the contiguous United States.  
  • Must not be a for-profit institution. 

 

EXCEPTIONAL PROJECTS GRANT 

Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant.  

This award recognizes creative, unique and innovative research related to breast cancer. 

The term of the Exceptional Project Grant is one year, beginning on March 1,2026. The grant provides salary support and project costs for a total of $100,000, distributed over a one-year period.  

Indirect costs, which are included in the $100,000 award, must be limited to 8% of total direct costs. 

Researchers should coordinate with their institutions, as BCA will accept a maximum of ONLY TWO LOIs PER INSTITUTION (YIG or XP).

 

Qualifications 

  • This grant is open to applicants at institutions in the contiguous United States. 
  • No for-profit institutions may apply.  

 

Funding Type
Internal Deadline
External Deadline
March 31, 2025 (LOI)
Solicitation Type

HRSA-25-066 Behavioral Health Workforce Education and Training Program for Paraprofessionals

Limit: 1 // Tickets Available: 0 

J.S. De La Rosa (Comprehensive Ceter for Pain and Addiction) - Continuing Application 

Purpose
The purpose of the BHWET Program for Paraprofessionals is to develop and expand community-based experiential training such as field placements and internships to increase the skills, knowledge and capacity of students preparing to become mental health workers, peer support specialists, and other behavioral health paraprofessionals.

The program has a special focus on developing knowledge and understanding of the needs of children, adolescents, and transitional-age youth who have experienced trauma and are at risk for behavioral health disorders including anxiety, depression, and substance use disorder. The program also emphasizes developmental opportunities and educational support in interprofessional collaboration by using team-based care in integrated behavioral health and primary care settings to improve the distribution of a well-trained behavioral health workforce. The program also aims to recruit a workforce that is interested in serving high need and high demand areas.

For the purpose of this NOFO, all training will be separated into two levels:
• Level 1: Pre-service: Includes didactic and experiential field training.
• Level 2: In-service (optional): Training at a registered Department of Labor apprenticeship site.

All paraprofessional training that does not fall under the definition of a registered apprenticeship will be defined as Level 1: Pre-service training as further explained in
Program Requirements and Expectations. Registered apprenticeships (Level 2) are not a program requirement. You are not required to implement Level 2 in your proposal to be considered eligible for this program. If you are implementing Level 2 in your proposed training project, you can receive an additional 5 points in Criteria 2: Response/Approach.

Application Limits
You may not submit more than one application per Unique Entity Identifier (UEI). If you submit more than one application under the same UEI, we will only accept the last on-time submission.

More than one application may be submitted from the same organization under separate UEIs.

Communication within your organization is encouraged to prevent duplication and to promote collaboration.

Internal Deadline
External Deadline
3/18/2025